The aim of this study is to evaluate and compare the hypotensive efficacy at 24 months between two implants in glaucoma surgery. Non-perforating deep sclerectomy surgery with non-resorbable uveoscleral implant associated with absorbable collagen matrix versus non-perforating deep sclerectomy surgery with isolated absorbable collagen matrix implant.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients older than 18 years of age
Primary or secondary open-angle glaucoma
High intraocular pressure (greater than or equal to 18mmHg) despite using maximum medical treatment
Intolerance to medication.
You may not be if
Patients with previous glaucoma surgery
Previous ocular surgery in the last 6 months
Previous history of Laser trabeculoplasty in the last 12 months
Moderate or severe diabetic retinopathy
Active or recurrent eye disease (uveitis)
Plateau iris
Ocular neovascularization
Aphakia
Neovascular angle-closure glaucoma
Previous history of intraocular or extraocular malignant neoplasm
Pregnancy or lactation period, axial length\> 26mm and \<20mm
Unwillingness for participating
Clareo Health | Efficacy and Safety of Non-resorbable Uveoscleral Implant Versus Absorbable Collagen Matrix in Non-perforating Deep Sclerectomy
